Artal Group S.A. - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 100 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 2.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$3,827,000
+2.1%
360,0000.0%0.15%
-1.3%
Q3 2019$3,748,000
-32.0%
360,0000.0%0.15%
-32.7%
Q2 2019$5,515,000
+7.3%
360,000
-10.0%
0.22%
+6.2%
Q1 2019$5,140,000
+35.3%
400,0000.0%0.21%
+48.9%
Q4 2018$3,800,000
-42.8%
400,0000.0%0.14%
-18.5%
Q3 2018$6,640,000
+3.4%
400,0000.0%0.17%
+27.2%
Q2 2018$6,420,000
+4.9%
400,0000.0%0.14%
+76.6%
Q1 2018$6,120,000
+96.2%
400,000
+100.0%
0.08%
+63.8%
Q4 2017$3,120,000
+12.4%
200,000
-20.0%
0.05%
-2.1%
Q3 2017$2,775,000
+20.7%
250,0000.0%0.05%
+20.0%
Q2 2017$2,300,000
+169.0%
250,000
+150.0%
0.04%
+110.5%
Q1 2017$855,000
-59.6%
100,000
-41.2%
0.02%
-75.6%
Q3 2014$2,118,000
-15.1%
170,0000.0%0.08%
-22.8%
Q2 2014$2,494,000
-21.0%
170,000
+9.7%
0.10%
-11.4%
Q1 2014$3,156,000
-5.3%
155,000
-8.8%
0.11%
-4.2%
Q4 2013$3,332,000170,0000.12%
Other shareholders
STEMLINE THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
VHCP Management II, LLC 315,980$3,381,0001.62%
VHCP Management, LLC 135,420$1,449,0001.56%
Eventide Asset Management 851,400$9,110,0000.59%
CARL DOMINO INC 26,000$278,0000.30%
SABBY MANAGEMENT, LLC 357,806$3,829,0000.22%
Telemetry Investments, L.L.C. 25,016$268,0000.15%
J. Goldman & Co LP 199,886$2,139,0000.14%
BAILARD, INC. 123,785$1,324,0000.12%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 94,945$1,015,0000.07%
Candriam S.C.A. 244,000$2,611,0000.06%
View complete list of STEMLINE THERAPEUTICS INC shareholders